LadRx Corporation 0I5R.L Stock
LadRx Corporation Price Chart
LadRx Corporation 0I5R.L Financial and Trading Overview
LadRx Corporation stock price | 1 USD |
Previous Close | 7.78 USD |
Open | 0 USD |
Bid | 0 USD x N/A |
Ask | 0 USD x N/A |
Day's Range | 0 - 0 USD |
52 Week Range | 0 - 8 USD |
Volume | 1.52K USD |
Avg. Volume | 11.92K USD |
Market Cap | 2.16M USD |
Beta (5Y Monthly) | 2.011267 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.355 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
0I5R.L Valuation Measures
Enterprise Value | 3.64M USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | -0.84 |
Trading Information
LadRx Corporation Stock Price History
Beta (5Y Monthly) | 2.011267 |
52-Week Change | 6263.63% |
S&P500 52-Week Change | 20.43% |
52 Week High | 8 USD |
52 Week Low | 0 USD |
50-Day Moving Average | 1.05 USD |
200-Day Moving Average | 1.05 USD |
0I5R.L Share Statistics
Avg. Volume (3 month) | 11.92K USD |
Avg. Daily Volume (10-Days) | 7.48K USD |
Shares Outstanding | 33.64M |
Float | 381.54K |
Short Ratio | N/A |
% Held by Insiders | N/A |
% Held by Institutions | N/A |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor | 0.01:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -69.69% |
Return on Equity (ttm) | -368.40% |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | -4332090 USD |
Net Income Avi to Common (ttm) | -4403350 USD |
Diluted EPS (ttm) | -0.355 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 606.37K USD |
Total Cash Per Share (mrq) | 1.26 USD |
Total Debt (mrq) | 182.08K USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 0.441 |
Book Value Per Share (mrq) | -3.877 |
Cash Flow Statement
Operating Cash Flow (ttm) | -4047169 USD |
Levered Free Cash Flow (ttm) | -2598448 USD |
Profile of LadRx Corporation
Country | United Kingdom |
State | CA |
City | Los Angeles |
Address | 11726 San Vicente Boulevard |
ZIP | 90049 |
Phone | 310-826-5648 |
Website | https://www.cytrx.com |
Industry | |
Sector(s) | |
Full Time Employees | 3 |
LadRx Corporation, a biopharmaceutical company, engages in research and development of chemotherapeutic drugs for solid tumors. Its pre-clinical therapeutics comprise linker activated drug releases 7, 8, 9, and 10 targeted against cancer. In addition, the company's Linker Activated Drug Release technology platform consists of an organic backbone, as well as develops albumin companion diagnostic to identify patients with cancer. The company was formerly known as CytRx Corporation and changed its name to LadRx Corporation in September 2022. LadRx Corporation was incorporated in 1985 and is headquartered in Los Angeles, California.
Q&A For LadRx Corporation Stock
What is a current 0I5R.L stock price?
LadRx Corporation 0I5R.L stock price today per share is 1 USD.
How to purchase LadRx Corporation stock?
You can buy 0I5R.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for LadRx Corporation?
The stock symbol or ticker of LadRx Corporation is 0I5R.L.
How many shares does LadRx Corporation have in circulation?
The max supply of LadRx Corporation shares is 309.28K.
What is LadRx Corporation Price to Earnings Ratio (PE Ratio)?
LadRx Corporation PE Ratio is now.
What was LadRx Corporation earnings per share over the trailing 12 months (TTM)?
LadRx Corporation EPS is -0.355 USD over the trailing 12 months.